<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01403740</url>
  </required_header>
  <id_info>
    <org_study_id>2011/HEM/001</org_study_id>
    <nct_id>NCT01403740</nct_id>
  </id_info>
  <brief_title>Turkish Acquired Haemophilia Registry</brief_title>
  <acronym>EHEM</acronym>
  <official_title>Observational Acquired Haemophilia Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turkish Society of Hematology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turkish Society of Hematology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Turkish Acquired Haemophilia Registry is a database in which information about clinical
      features and therapeutic management of acquired haemophilia is collected in Turkey.This is a
      multicentre, retrospective and prospective registry of subjects diagnosed and/or treated for
      acquired haemophilia. Patients will be registered and the response to different therapies,
      details of each bleeding episode and the outcome of haemostatic and immunosuppressive therapy
      (IST) will be recorded. Any male or female subject diagnosed with inhibitors to FVIII or
      other factors and treated for acquired haemophilia can be entered on the registry. Patients
      will be treated according to local practice. No additional tests or procedures are required
      by the registry. The retrospective period will not be time-limited and data will be collected
      from those recorded in the hospital notes. The prospective period will begin in September
      1.2011, and will last for two years.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Acquired Haemophilia</condition>
  <arm_group>
    <arm_group_label>Acquired haemophilia patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin</intervention_name>
    <description>According to local clinical standards</description>
    <arm_group_label>Acquired haemophilia patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample for coagulation factor determination
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acquired haemophilia diagnosed and/or treated in haematology clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acquired haemophilia diagnosis, written consent

        Exclusion Criteria:

          -  Being unable to give written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muzaffer A Demir, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>THD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dilek Solakoglu, MD</last_name>
    <phone>902123253232</phone>
    <email>dileksolakoglu@cortexiletisim.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Volkan Aydin, MD</last_name>
    <phone>902123253232</phone>
    <email>volkanaydin@cortexiletisim.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Trakya University Haematology Clinic</name>
      <address>
        <city>Edirne</city>
        <zip>22030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Muzaffer A Demir, Prof</last_name>
      <phone>902842351041</phone>
      <email>mdemir@trakya.edu.tr</email>
    </contact>
    <contact_backup>
      <last_name>Dilek Solakoglu, MD</last_name>
      <phone>902123253232</phone>
      <email>dileksolakoglu@cortexiletisim.com</email>
    </contact_backup>
    <investigator>
      <last_name>Muzaffer A Demir, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2011</study_first_submitted>
  <study_first_submitted_qc>July 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2011</study_first_posted>
  <last_update_submitted>July 26, 2011</last_update_submitted>
  <last_update_submitted_qc>July 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Turkish Society of Hematology</name_title>
    <organization>Turkish Society of Hematology</organization>
  </responsible_party>
  <keyword>acquired haemophilia</keyword>
  <keyword>factor VIII</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rituximab</mesh_term>
    <mesh_term>Azathioprine</mesh_term>
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

